about
Modulation of Inflammatory Responses by Wnt/β-Catenin Signaling in Dendritic Cells: A Novel Immunotherapy Target for Autoimmunity and CancerNonspecific down-regulation of CD8+ T-cell responses in mice expressing human papillomavirus type 16 E7 oncoprotein from the keratin-14 promoter.CD45 tyrosine phosphatase-activated p59fyn couples the T cell antigen receptor to pathways of diacylglycerol production, protein kinase C activation and calcium influxClonal deletion of specific thymocytes by an immunoglobulin idiotype.Antigen localization and migration in immunity and tolerance.Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation.The lost chord: microchimerism and allograft survival.Role of interleukin 12 and costimulators in T cell anergy in vivo.Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease.Dendritic cell control of tolerogenic responses.Human alveolar macrophages present antigen ineffectively due to defective expression of B7 costimulatory cell surface moleculesT-cell tolerance toward a transgenic beta-cell antigen and transcription of endogenous pancreatic genes in thymusImmune competence of cancer-reactive T cells generated de novo in adult tumor-bearing miceAutoantibodies to vimentin cause accelerated rejection of cardiac allografts.The molecular mechanisms of regulatory T cell immunosuppressionIn vivo role of interleukin 4 in T cell tolerance induced by aqueous protein antigen.Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.An autoimmune disease with multiple molecular targets abrogated by the transgenic expression of a single autoantigen in the thymus.Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagenCytotoxic T lymphocytes to an unmutated tumor rejection antigen P1A: normal development but restrained effector function in vivo.Perinatal blockade of b7-1 and b7-2 inhibits clonal deletion of highly pathogenic autoreactive T cells.In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes.Transferable anergy: superantigen treatment induces CD4+ T cell tolerance that is reversible and requires CD4-CD8- cells and interferon gammaImmunotherapeutic targeting of LIGHT/LTβR/HVEM pathway fully recapitulates the reduced cytotoxic phenotype of LIGHT-deficient T cells.Epitope-specific tolerance induction with an engineered immunoglobulin.The role of FOXP3 in regulating immune responses.Current status of allograft tolerance in intestinal transplantation.A cancer vaccine based on fluorine-modified sialyl-Tn induces robust immune responses in a murine model.Immunologic mechanisms and therapy in multiple sclerosis.Images of self: a model for tonic peripheral tolerance.Intrathymic and extrathymic tolerance in bone marrow chimeras.Effector T-cell induction and T-cell memory versus peripheral deletion of T cells.Tolerance and ways to break it.Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic targetInduction of anergy in Th1 lymphocytes by oral tolerance. Importance of antigen dosage and frequency of feeding.Burnet oration. Autoimmunity: paradigms of Burnet and complexities of today.Enhancement of class II-restricted T cell responses by costimulatory NK receptors for class I MHC proteins.Pancreatic islet allograft immunity and tolerance: the two-signal hypothesis revisited.Current concepts and advances in clinical laboratory testing for autoimmune diseases.Oncogene transformation can induce tolerogenicity in murine macrophages after down-regulation of immunogenicity without altering major histocompatibility complex antigen expression.
P2860
Q28079530-4277E313-8117-454C-9DEA-56209D418731Q33842444-D6A8BEB7-C76C-4875-A86C-BFDE770F502EQ33938606-F0CA47FC-5788-4A73-92FB-C52D78558C72Q34042176-2FC0BB97-E791-4733-9BCC-A665C7262B55Q34239865-98FF0349-B800-4A50-B658-5B5A04B2507AQ34302109-6A4586E6-FE4A-4790-BC92-F7070BF91DF2Q34359678-C9517BBE-D13D-4EE0-A77A-003817A0855DQ34440866-0F4D428C-9A9E-4A56-8BAF-AD8D8A6911D3Q34788330-2F15D852-1BBC-4EDC-975B-C2FBF55D6789Q34982085-D0CDBC31-4F99-47E2-95D5-0D46CF86B5FAQ35554497-F3714A55-F7BD-4404-B5A5-EB189A135BFAQ35592666-088B29B9-2410-492E-9C13-B73349393CE5Q35615758-0EA91BB1-8AF1-421D-A324-6DD6AD347632Q35691658-E4FF32C8-3CF2-4BE1-A363-70BBEA79AC75Q35928046-BC200225-3960-4AD0-AB60-3D5E0E789AE4Q36361359-0E0B7442-2A8F-4A03-A150-A03947863C4FQ36361966-7550541F-A9B6-4BFE-B8DC-875FD48526BEQ36362080-BA37247E-BA09-418A-81E2-1312E89A1542Q36363255-E681A0CB-4F99-44C1-B49A-E8B569CCB0DDQ36367821-D0A547C2-8406-450A-9F0D-D4840321EC34Q36370130-02E2F2F9-6746-47FC-AA49-35A567D6CE53Q36375838-81650040-F0CE-4006-94E4-8AB8BC5B5E02Q36380329-ECAC6DCA-EE63-4059-823D-7FD37488DA3CQ37138965-CE716D39-7D54-47FB-9857-64C23605BBDFQ37612708-55CA4D6D-6E63-4A05-8B13-7988A39B9385Q38129079-990F1146-0C44-448A-AB4A-03BA6790AECBQ38170420-DAF1A693-97F0-4889-92C4-2A8B7E611715Q38767397-54870A44-2113-48F4-AB69-209C95F36219Q40433260-50DA4479-F04C-4A51-A03C-53C1F77BCCE8Q40618214-02A957AF-375E-424B-9354-3B447410A0CCQ40774138-F09ADFBE-7A49-4DF9-9C28-587496C42465Q40774151-E4B39DFB-CD07-4D19-8D60-FD753F9644E8Q40844514-A5E1122E-8C45-494C-9CE5-4B6098BC4FFFQ40865882-C52B1FEB-A003-45FA-9AD7-B1148B7A0464Q40976325-C26A4216-6471-4415-841C-E5592A3646B2Q41116678-59C3056D-4115-41A1-AB42-0DE5CC608D40Q41144561-04EA4433-7D45-4006-8A36-41FC83DA75B6Q41326977-67461609-0612-4E50-998C-E6EF3DFDFFA1Q41534109-971EAB8B-EA54-4005-A6CD-C7FAEB4FEE5AQ41544838-A7AC05FD-5330-42EE-BF6E-C144C1466533
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Peripheral T cell tolerance.
@ast
Peripheral T cell tolerance.
@en
type
label
Peripheral T cell tolerance.
@ast
Peripheral T cell tolerance.
@en
prefLabel
Peripheral T cell tolerance.
@ast
Peripheral T cell tolerance.
@en
P1476
Peripheral T cell tolerance.
@en
P2093
P356
10.1146/ANNUREV.IY.10.040192.000411
P577
1992-01-01T00:00:00Z